These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunotherapy of malignant tumors in man]. Govalle VI Vopr Onkol; 1976; 22(3):99-109. PubMed ID: 779262 [No Abstract] [Full Text] [Related]
3. Bone marrow and thymus transplantation in ataxia-telangiectasia. Buckley RH Birth Defects Orig Artic Ser; 1975; 11(1):421-4. PubMed ID: 125117 [TBL] [Abstract][Full Text] [Related]
4. Combination immunotherapy in chronic mucocutaneous candidiasis. Synergism between transfer factor and fetal thymus tissue. Ballow M; Hyman LR Clin Immunol Immunopathol; 1977 Nov; 8(3):504-12. PubMed ID: 912947 [No Abstract] [Full Text] [Related]
5. [Therapeutic prospects in some immune deficiency syndromes and other pathological conditions connected with immune disorders]. Kraj M; Cieśluk S Acta Haematol Pol; 1976 OCT-DEC; 7(4):327-35. PubMed ID: 793282 [No Abstract] [Full Text] [Related]
6. [Pros and cons of the use of immunotherapeutic procedures with special reference to adoptive immunotherapy in proliferative diseases]. Schneiberg K Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(3):337-57. PubMed ID: 6159273 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of dysfunction of cellular immunity and the prospect for future]. Igarashi T; Azuma I; Yamamura Y Nihon Rinsho; 1978; 36(5):1011-7. PubMed ID: 353324 [No Abstract] [Full Text] [Related]
8. [Therapeutic prospects in severe primary immune deficiency]. Seligmann M; Weisgerber C Presse Med (1893); 1970 Feb; 78(8):357-8. PubMed ID: 4907367 [No Abstract] [Full Text] [Related]
11. [Indications and limitations of bacteriological isolation in severe combined immunologic deficiencies]. Mozziconacci P Nouv Presse Med; 1974 Jun; 3(22):1419-20. PubMed ID: 4601859 [No Abstract] [Full Text] [Related]
12. Congenital deficiencies of the thymus dependent system of cellular immunity. Treatment by transplantation of bone-marrow or fetal tissues. Dooren LJ Padiatr Padol; 1972; 7(2):124-7. PubMed ID: 4404609 [No Abstract] [Full Text] [Related]
13. Current experience with organ transplantation. Jonasson OM Clin Orthop Relat Res; 1972 Sep; 87():9-14. PubMed ID: 4562201 [No Abstract] [Full Text] [Related]
15. Minnesota experience in bone-marrow transplantation in man, 1968 to June 1973. Park BH; Biggar WD; Good RA Transplant Proc; 1974 Dec; 6(4):379-83. PubMed ID: 4280164 [No Abstract] [Full Text] [Related]
16. [Immunotherapy of leprosy in 1981]. Wallach D Acta Leprol; 1982; (86-87):165-76. PubMed ID: 6815984 [No Abstract] [Full Text] [Related]
17. The use of cell separation techniques and isantibody to host antigens in the treatent of severe combined immunodeficiency disease with HL-A incompatible maternal marrow. Gelfand EW; Phillips RA; Miller RG; McCulloch EA; Rosen FS Exp Hematol; 1974; 2(3):122-30. PubMed ID: 4156326 [No Abstract] [Full Text] [Related]
18. Proceedings: a comparison of methods of immunological reconstitution of immunologically unresponsive mice. Hamilton DN; Reid CE; Gilmour DG; Bell PR Br J Surg; 1973 Nov; 60(11):900. PubMed ID: 4752741 [No Abstract] [Full Text] [Related]
19. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens. Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474 [No Abstract] [Full Text] [Related]
20. [Treatment of severe combined immune deficiency with fetal thymus and bone marrow transplantation, as well as with thymosin]. Timár L; Budai J; Jánossa M; Mándi B; Pongrácz J; Walcz E; Kelemen E Orv Hetil; 1986 Jul; 127(28):1687-95. PubMed ID: 3526243 [No Abstract] [Full Text] [Related] [Next] [New Search]